EMRA Trivia Night at ACEP23

Trivia Night Banner.png

Event Details

When: Tuesday, October 10 from 7 – 8:30 pm
Where: The Gallery located at the Marriott Downtown Philadelphia

Join EMRA and BTG Pharmaceuticals for an interactive, fun-filled, test your knowledge trivia session! Come as a single or 2-member team, and bring your knowledge of toxicology, wilderness medicine, prehospital and disaster, and critical care. Enjoy drinks and appetizers while you compete for prizes. This is an event you won’t want to miss!

Sample question #1:

This is an effective choice for treating massive acetaminophen overdose. (Hint: You’ll find this tip in the EMRA and ACMT Medical Toxicology Guide.)
A. Sodium bicarbonate
B. NAC
C. Fomepizole
D. All of these

Sample question #2:

Meropenem can be used to treat:
A. Valproic acid overdose
B. Acetaminophen overdose
C. Marine envenomations
D. Pit viper envenomations

Think you know the answers? Then join us on Tuesday, October 10 at 7 pm for guaranteed fun!

Learn more about BTG Pharmaceuticals

Attending ACEP? Visit us at booth #1108

Supported by:

btg-logo.jpg

Related Content

May 18, 2024

Getting Started in EM Research: Lessons from Rising Stars

The EMRA Research Committee interviewed 4 soon-to-be legends in the emergency medicine research community, from residents to established faculty, to understand their experiences. Our interviewees — Mat Goebel, MD, MAS; Corey Hazekamp, MD, MS; Vinitha Jacob, MD, PhD; and Laura Harding-Jackson, DO, PhD — discussed how they got their start in EM research, relevant training, current focuses and niches, and more.

Feb 12, 2021

Magnolia Regional Health Center

Drs. Carlton and Baker discuss the Washington University at Magnolia Regional Health Center

May 21, 2024

ABEM Board Certification Changes: What You Need to Know

The financial, equitable, and logistical implications of a new, in-person ABEM certifying exam as planned — especially one that replaces the current virtual OCE format — warrants further consideration and discussion with the most affected stakeholders: trainees and early-career physicians.